Institute of Molecular Physiology and Genetics
Slovak Research and Development Agency (SRDA): |
|
 |
APVV-14-0334 Possible dual function of P-glycoprotein in leukemia cells: efflux pump and regulatory protein (2015-2018) Principal investigator: Zdena Sulová |
| APVV-16-0439 The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects (2017-2021) Principal Investigator (IMPG SAS): Zdena Sulová |
|
|
APVV-15-0303 Defense mechanisms of neoplastic cells against chemical stress (2016-2020) Principal investigator (Faculty of Chemical and Food Technology STU in Bratislava): Albert Breier Principal investigator at IMPG SAS: Zdena Sulová |
| APVV-15-0372 Novel synergistic antitumour properties of nuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells (2016-2020) Principal investigator (Institute of Experimental Endocrinology BMC SAS): Július Brtko Principal investigator at IMPG SAS: Zdena Sulová |
|
| APVV-15-0641 Smart MoS2 platform for cancer diagnosis and targeted treatment (2016-2020) Principal investigator (Institute of Physics SAS): Peter Šiffalovič Principal investigator at IMPG SAS: Albert Breier |
|
| APVV-14-0753 Biochips and biosensors for glycorecognition, their development, preparation and application in cancer research (2015-2019) Principal investigator (Institute of Chemistry, SAS): Jaroslav Katrlík Principal investigator at IMPG SAS: Zdena Sulová |
|
Grant Agency for Science (VEGA) |
|
 |
VEGA 2/0057/18 Analyses of allele-specific regulation of CD33 expression (2018 – 2021) Principal Investigator: Jana Královičová |
| VEGA 2/0157/18 The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein (2018-2021) Principal Investigator: Viera Boháčová |
|
|
VEGA 2/0122/17 Study of changes in expression of some regulatory and functional proteins connected with the presence of P-gp protein in leukemic cells (2017-2020) Principal investigator: Zdena Sulová |
|
VEGA 2/0156/16 The effect of endoplasmic reticulum stress inductors and proteaosome inhibitors on leukemia cell line L1210, SKM-1 and MOLM-13 with induced P-glycoprotein overexpression (2016-2018) Principal investigator: Mário Šereš |
|
VEGA 2/0028/15 Changes of leukemia cells drug sensitivity induced by changes of membrane drug transporters expression profile (2015-2018) Principal investigator: Albert Breier |